Windstar Medical

Sector
Consumer
Fund
Fund IV
Year
2020
Location
Germany
Status
Current

Windstar Medical is a leading German consumer healthcare OTC platform that designs, develops and commercialises branded consumer health and private label products.

Key facts

Branded revenues

57%

share

Founded in 1993, Windstar Medical has a history of establishing best-in-class medical formulations.

Windstar Medical

Premium high-growth branded products

The business offers a wide range of premium high-growth branded products in Germany and beyond, including SOS (wound care/disinfectants), Zirkulin (gastro-intestinal care), GreenDoc (mental wellbeing) and EyeMedica (eye health).

Our investment

Windstar’s asset-light business model, industry-leading operational capabilities and attractive growth profile display typical Oakley deal characteristics.

In October 2020, we acquired a majority stake in the business to support the management team to scale the business through continued product innovation, digitalisation, and accretive acquisitions in high-growth branded and D2C verticals.

In 2021, WindStar acquired L.A.B. Cosmetics in order to break in to the highly attractive ‘clean beauty’ segment.

Quote Rene Flaschker

Oakley showed a deep understanding of our sector from the outset and we look forward to working with them to drive further growth in our business.

Rene Flaschker

CEO & MD Windstar Medical

Market dynamics

WindStar Medical benefits from the long-term structural growth of Germany’s consumer health market. This growth is being driven both by demographic trends, such as an ageing population, and a shift in consumer preferences driven by factors such as increased awareness of physical and mental wellbeing and willingness to prevent illness.

Our origination network helps us source investments others cannot. Often, we are the first institutional investor in our portfolio companies.

Back to top